AstraZeneca ‘mulling split from Chinese business amid rising tensions’

AstraZeneca is looking at plans to spin off its Chinese businesses to protect it from geopolitical tension, according to a report.

Citing people familiar with the situation, the Financial Times said the British-Swedish drugs giant has been in talks with bankers for several months.The plan would separate Astra’s Chinese operations into a separate company whose shares would be ...

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

businessposthq /  🏆 8. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

AstraZeneca ‘mulling split from Chinese business amid rising tensions’Drugs giant hopes to be better protected against political reprisals from Beijing against foreign companies
더 많은 것을 읽으십시오 »

AstraZeneca drafts plan to spin off China business amid tensionsAnglo-Swedish drugmaker views listing a separate unit in Hong Kong as potential shelter from global strife via IrishTimesBiz
더 많은 것을 읽으십시오 »